Order Article Reprints

Handke AE, Orf C, Dellino M, Garcia-Schürmann LM, Radtke JP, Noldus J, Roghmann F, Palisaar R-J, Berg S, Tully KH. Upstaging of Patients Diagnosed with Favorable Intermediate-Risk Prostate Cancer—Is Active Surveillance Really a Suitable Approach for All These Patients? Cancers. 2025; 17(21):3444. https://doi.org/10.3390/cancers17213444

Handke, Analena E., Christopher Orf, Martina Dellino, Leon Miguel Garcia-Schürmann, Jan Philipp Radtke, Joachim Noldus, Florian Roghmann, Rein-Jüri Palisaar, Sebastian Berg, and Karl H. Tully. 2025. "Upstaging of Patients Diagnosed with Favorable Intermediate-Risk Prostate Cancer—Is Active Surveillance Really a Suitable Approach for All These Patients?" Cancers 17, no. 21: 3444. https://doi.org/10.3390/cancers17213444

Handke, A. E., Orf, C., Dellino, M., Garcia-Schürmann, L. M., Radtke, J. P., Noldus, J., Roghmann, F., Palisaar, R.-J., Berg, S., & Tully, K. H. (2025). Upstaging of Patients Diagnosed with Favorable Intermediate-Risk Prostate Cancer—Is Active Surveillance Really a Suitable Approach for All These Patients? Cancers, 17(21), 3444. https://doi.org/10.3390/cancers17213444